Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome.

Reduced gene dosage of ribosomal protein subunits has been implicated in 5q- myelodysplastic syndrome and Diamond Blackfan anemia, but the cellular and pathophysiologic defects associated with these conditions are enigmatic. Using conditional inactivation of the ribosomal protein S6 gene in laboratory mice, we found that reduced ribosomal protein gene dosage recapitulates cardinal features of t...

متن کامل

MYELOID NEOPLASIA Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome

Departments of 1Genetics and 2Pathology, and 3Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA; 4Departments of Pathology and Clinical Laboratories, Memorial Sloan-Kettering Cancer Center, New York, NY; 5Department of Pediatrics, Stanford University, Stanford, CA; 6Department of Basic Medical Sciences, Purdue University, West Lafayette, IN; and 7Hudso...

متن کامل

Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome

In this issue of the Revista Brasileira de Hematologia e Hemoterapia, Duarte et al.1 present data on the role of p53 protein expression and prognosis of patients with low-risk myelodysplastic syndrome (MDS). In a cohort of 38 patients, the authors demonstrated an association between mutant p53 protein expression and shortened survival. MDS is a clinically heterogeneous disorder.2 Patients with ...

متن کامل

Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome

BACKGROUND At the time of diagnosis, more than 50% of patients with myelodysplastic syndrome have a normal karyotype and are classified as having a favorable prognosis. However, these patients often show very variable clinical outcomes. Furthermore, current diagnostic tools lack the ability to look at genetic factors beyond karyotyping in order to determine the cause of this variability. OBJE...

متن کامل

Gene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome

Myelodysplastic syndromes (MDSs) are a clonal bone marrow (BM) disease characterized by ineffective hematopoiesis, dysplastic maturation and progression to acute myeloid leukemia (AML). Methylation silencing of HRK has been found in several human malignancies. In this study, we explored the association of HRK methylation status with its expression, clinical parameters and MDS subtypes in MDS pa...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Blood

سال: 2011

ISSN: 0006-4971,1528-0020

DOI: 10.1182/blood-2010-11-318584